COVID-19 Leading to Accelerated Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Dermatomyositis

被引：0
|
作者：
Dandu, S. [1 ]
Farhat, F. [1 ]
Akhlaq, H. [1 ]
Udongwo, N. [1 ]
Nannepaga, S. [1 ]
Nadhim, A. [2 ]
Abu Homoud, A. [3 ]
机构：
[1] Jersey Shore Univ, Med Ctr, Internal Med, Neptune, NJ USA
[2] JSUMC, Neptune, NJ USA
[3] Jersey Shore Univ, Med Ctr, Pulm & Crit Care, Neptune, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1445
引用
收藏
页数：2
相关论文
共 50 条
  • [41] ANTI-MDA5 DERMATOMYOSITIS: ECMO AS A BRIDGE TO LUNG TRANSPLANT IN REFRACTORY RAPIDLY PROGRESSIVE ILD
    Castro, Jose Luis Rodriguez
    Devine, Adam
    Garcia, Grettel Gonzalez
    Danckers, Mauricio
    Diaz, Raiko
    CHEST, 2024, 166 (04) : 3259A - 3260A
  • [42] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ANTI-MDA5-RELATED CLINICALLY AMYOPATHIC DERMATOMYOSITIS
    Cardenas, Carlos
    Gupta, Surbhi
    Kim, Jaehyun
    Kershaw, Corey
    Tomlinson, Andrew
    CHEST, 2019, 156 (04) : 1867A - 1868A
  • [43] Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis
    Nandy, A.
    Gaini, S.
    Sore, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (04) : 334 - 335
  • [44] Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease
    Biddle, Kathryn
    Agaoglu, Elif
    Brent, Geoffrey
    Adam, John
    Nockels, Rachel
    Loveridge, Adam
    Bazari, Farid
    Natkunarajah, Janakan
    Al-Shakarchi, Israa
    OXFORD MEDICAL CASE REPORTS, 2024, 2024 (06): : 249 - 254
  • [45] Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease
    Hata, Kenichiro
    Kotani, Takuya
    Matsuda, Shogo
    Fujiki, Youhei
    Suzuka, Takayasu
    Kiboshi, Takao
    Wada, Yumiko
    Shiba, Hideyuki
    Shoda, Takeshi
    Kagitani, Maki
    Takeuchi, Tohru
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [46] Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
    Li, Xiaomeng
    Liu, Yongmei
    Cheng, Linlin
    Huang, Yuan
    Yan, Songxin
    Li, Haolong
    Zhan, Haoting
    Li, Yongzhe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [47] Successful treatment of rapidly progressive interstitial lung disease complicated by a refractory pneumomediastinum in a patient with anti-MDA5 antibody-positive dermatomyositis
    Jiang, Lili
    Chen, Hong
    Duan, Lihua
    RHEUMATOLOGY & AUTOIMMUNITY, 2023, 3 (04): : 240 - 243
  • [48] Anti-MDA5 Is Associated with Rapidly-Progressive Interstitial Lung Disease and Poor Survival in US Patients with Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia, Siamak
    Oddis, Chester V.
    Sato, Shinji
    Kuwana, Masataka
    Aggarwal, Rohit
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S554 - S555
  • [49] Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis A case report
    Endo, Yushiro
    Koga, Tomohiro
    Suzuki, Takahisa
    Hara, Kazusato
    Ishida, Midori
    Fujita, Yuya
    Tsuji, Sosuke
    Takatani, Ayuko
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Igawa, Takashi
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Kuwana, Masataka
    Kawakami, Atsushi
    MEDICINE, 2018, 97 (15)
  • [50] Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis
    Wongjirattikarn, Rachot
    Chaowattanapanit, Suteeraporn
    Choonhakarn, Charoen
    So-ngern, Apichart
    Mahakkanukrauh, Ajanee
    Foocharoen, Chingching
    CASE REPORTS IN DERMATOLOGY, 2020, 12 (01): : 57 - 63
12345